| US 7,544,737 B2 | ||
| Macromolecular ketoaldehydes | ||
| Mitchell J. Poss, Antioch, Ill. (US); Henk Blom, Mundelein, Ill. (US); Alex Odufu, Hoffman Estates, Ill. (US); and Robert Smakman, Nigtevecht (Netherlands) | ||
| Assigned to Baxter International Inc., Deerfield, Ill. (US); and Baxter Healthcare S.A., Zurich (Switzerland) | ||
| Filed on Nov. 12, 2004, as Appl. No. 10/987,331. | ||
| Application 10/987331 is a division of application No. 10/376095, filed on Feb. 28, 2003, granted, now 6,861,473. | ||
| Prior Publication US 2005/0131141 A1, Jun. 16, 2005 | ||
| Int. Cl. C08F 220/12 (2006.01); C08L 29/00 (2006.01); C08F 16/34 (2006.01); C08F 16/36 (2006.01); C08F 12/02 (2006.01); C08F 112/02 (2006.01) | ||
| U.S. Cl. 524—818 [526/315; 526/316; 526/346] | 2 Claims |
| 1. A macromolecular composition comprising:
polystyrene;
a spacer group attached to a phenyl group of the polystyrene, wherein the spacer group is selected from the group consisting
of a substituted or an unsubstituted aliphatic group, a substituted or an unsubstituted alicyclic group, a substituted or
an unsubstituted aromatic group and combinations thereof; and
an alpha-ketoaldehyde group attached to the spacer group.
|